Twist Bioscience Corporation (NASDAQ:TWST) is reporting fourth quarter financial results on Monday 23rd November 2020, before market open.
According to analysts surveyed by Thomson Reuters, TWST is expected to report 4Q20 loss of $ 0.7 per share from revenue of $ 22.67 million.
For the full year, analysts anticipate top line of $ 80.91 million, while looking forward to loss of $ 3.73 per share bottom line.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 80.00 million ~ $ 84.00 million
Click Here For More Historical Outlooks Of Twist Bioscience Corporation
Previous Quarter Performance
Twist Bioscience Corporation disclosed loss for the third quarter of $ 0.67 per share, from the revenue of $ 21.21 million. The quarterly revenues expanded 55.96 percent compared with the same quarter last year. The consensus estimates are loss of $ 0.73 per share from $ 14.17 million in revenue. The bottom line results beat street analysts by $ 0.06 or 8.22 percent, at the same time, top line results outshined analysts by $ 7.04 million or 49.68 percent.
Stock Performance
Shares of Twist Bioscience Corporation traded up $ 1.06 or 0.93 percent on Friday, reaching $ 115.56 with volume of 477.20 thousand shares. Twist Bioscience Corporation has traded high as $ 117.70 and has cracked $ 110.62 on the downward trend
According to the previous trading day, closing price of $ 115.56, representing a 518.25 % increase from the 52 week low of $ 18.52 and a 2.72 % decrease over the 52 week high of $ 117.70.
The company has a market capital of $ 5.16 billion and is part of the Healthcare sector and Diagnostics & Research industry.
Conference Call
Twist Bioscience Corporation will be hosting a conference call at 8:00 AM eastern time on 23rd November 2020, to discuss its 4Q20 financial results with the investment community. The participants may dial, (866) 688-0947 Toll Free or (409) 217-8781 Toll Number, and the passcode is 2947139 in order to access the live audio call. A live webcast with presentations will be available on the Internet by visiting the Company website www.twistbioscience.com
Twist Bioscience Corporation, a synthetic biology company, manufactures and sells synthetic DNA-based products. The companys DNA synthesis platform enables the manufacturing of synthetic DNA by writing DNA on a silicon chip. It offers synthetic DNA-based products, including synthetic genes, tools for sample preparation, antibody libraries for drug discovery and development, and DNA as a digital data storage medium.
